53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
The study was conducted at Sewanee University, TN, USA, in early 2021 and focused on collecting cough acoustic signatures for respiratory disease screening. It involved around 2000 students tested weekly for SARS-CoV-2. The study recorded 4302 coughs from 960 participants over 11 weeks, all COVID-19 negative. The process took about 30 seconds per participant. The project's goal was to develop and implement reliable, quick acoustic screening tools, emphasizing the need for high-quality datasets and logistical insights. This study contributes significantly to acoustic epidemiology, especially in the context of COVID-19 and SARS-CoV-2 research
